Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanhua Yue

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 14, 2016
The Successful Complete Remission Induction by Sorafenib Monotherapy in a FLT3-D835Y-Positive Patient with Refractory Acute Monocytic LeukemiaYanhua Yue, Song Jin, Ting Xu, et al.
The American Journal of Case Reports|October 6, 2020
Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature ReviewYanhua Yue, Wei Wei, Yanting Guo, et al.
Hematology (Amsterdam, Netherlands)|January 3, 2025
Time to progression predicts outcome of patients with multiple myeloma that can be influenced by autologous hematopoietic stem cell transplantationYanhua Yue, Yingjie Miao, Yifang Zhou, et al.
Hematology (Amsterdam, Netherlands)|December 19, 2024
Malnutrition defined by Controlling Nutritional Status score was independently associated with prognosis of diffuse large B-cell lymphoma primarily on elderly patientsFei Wang, Luo Lu, Haoyu Zang, et al.
Annals of Hematology|January 20, 2023
Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximabFei Wang, Luo Lu, HuiJuan Chen, et al.
Hematology (Amsterdam, Netherlands)|July 18, 2015
Deep molecular responses achieved in chronic myeloid leukemia in chronic phase patients with BCR-ABL1 >10% at 3 months who are early switched to nilotinibYanhua Yue, Xiaomin Gui, Xuefeng He, et al.
Frontiers in Immunology|March 18, 2026
Efficacy analysis of iptacopan in a patient with thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: a case reportZixuan Zhao, Lin Guo, Jiao Ge, et al.
International Journal of Biological Macromolecules|June 19, 2026
Structural and functional characterization of Acyl-CoA Synthetase Long-Chain Family Member 3 (ACSL3) and its targeted inhibition by gramicidin in multiple myelomaYanhua Yue, Wenjing Du, Yingjie Miao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 2, 2020
Decitabine and all-trans retinoic acid synergistically exhibit cytotoxicity against elderly AML patients via miR-34a/MYCN axisYang Cao, Yue Liu, Limei Shang, et al.
BMC Cancer|November 29, 2023
Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcomeFei Wang, Silu Cui, Luo Lu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 14, 2016
The Successful Complete Remission Induction by Sorafenib Monotherapy in a FLT3-D835Y-Positive Patient with Refractory Acute Monocytic LeukemiaYanhua Yue, Song Jin, Ting Xu, et al.
The American Journal of Case Reports|October 6, 2020
Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature ReviewYanhua Yue, Wei Wei, Yanting Guo, et al.
Hematology (Amsterdam, Netherlands)|January 3, 2025
Time to progression predicts outcome of patients with multiple myeloma that can be influenced by autologous hematopoietic stem cell transplantationYanhua Yue, Yingjie Miao, Yifang Zhou, et al.
Hematology (Amsterdam, Netherlands)|December 19, 2024
Malnutrition defined by Controlling Nutritional Status score was independently associated with prognosis of diffuse large B-cell lymphoma primarily on elderly patientsFei Wang, Luo Lu, Haoyu Zang, et al.
Annals of Hematology|January 20, 2023
Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximabFei Wang, Luo Lu, HuiJuan Chen, et al.
Hematology (Amsterdam, Netherlands)|July 18, 2015
Deep molecular responses achieved in chronic myeloid leukemia in chronic phase patients with BCR-ABL1 >10% at 3 months who are early switched to nilotinibYanhua Yue, Xiaomin Gui, Xuefeng He, et al.
Frontiers in Immunology|March 18, 2026
Efficacy analysis of iptacopan in a patient with thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: a case reportZixuan Zhao, Lin Guo, Jiao Ge, et al.
International Journal of Biological Macromolecules|June 19, 2026
Structural and functional characterization of Acyl-CoA Synthetase Long-Chain Family Member 3 (ACSL3) and its targeted inhibition by gramicidin in multiple myelomaYanhua Yue, Wenjing Du, Yingjie Miao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 2, 2020
Decitabine and all-trans retinoic acid synergistically exhibit cytotoxicity against elderly AML patients via miR-34a/MYCN axisYang Cao, Yue Liu, Limei Shang, et al.
BMC Cancer|November 29, 2023
Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcomeFei Wang, Silu Cui, Luo Lu, et al.
Pageof 2